Pioglitazone reduces ER stress in the liver: direct monitoring of in vivo ER stress using ER stress-activated indicator transgenic mice
- PMID: 19789420
- DOI: 10.1507/endocrj.k09e-140
Pioglitazone reduces ER stress in the liver: direct monitoring of in vivo ER stress using ER stress-activated indicator transgenic mice
Abstract
It is known that endoplasmic reticulum (ER) stress is provoked under diabetic conditions and is possibly involved in the development of insulin resistance. In this study, using ER stress-activated indicator (ERAI) transgenic mice which express green fluorescent protein under ER stress conditions, we directly evaluated the effects of a diabetic agent pioglitazone on in vivo ER stress under diabetic conditions. In high fat and high sucrose diet-induced diabetic ERAI transgenic mice, 8 weeks of pioglitazone treatment reduced the accumulation of fat droplets in the liver and attenuated the development of insulin resistance. In the liver of the ERAI transgenic mice, ERAI fluorescence activity was clearly reduced as early as after 4 weeks of pioglitazone treatment, preceding the improvement of insulin resistance. In addition, after the pioglitazone treatment, serum free fatty acid and triglyceride levels were decreased, and serum adiponectin levels were increased. These data indicate that pioglitazone treatment suppresses ER stress in the liver which may explain, at least in part, the pharmacological effects of pioglitazone to reduce insulin resistance.
Similar articles
-
Direct monitoring of in vivo ER stress during the development of insulin resistance with ER stress-activated indicator transgenic mice.Biochem Biophys Res Commun. 2008 Feb 8;366(2):545-50. doi: 10.1016/j.bbrc.2007.11.182. Epub 2007 Dec 10. Biochem Biophys Res Commun. 2008. PMID: 18070597
-
Effect of pioglitazone treatment on endoplasmic reticulum stress response in human adipose and in palmitate-induced stress in human liver and adipose cell lines.Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E393-400. doi: 10.1152/ajpendo.90355.2008. Epub 2008 Jun 10. Am J Physiol Endocrinol Metab. 2008. PMID: 18544642 Free PMC article. Clinical Trial.
-
Hypoglycemic effect of polysaccharide enriched extract of Astragalus membranaceus in diet induced insulin resistant C57BL/6J mice and its potential mechanism.Phytomedicine. 2009 May;16(5):416-25. doi: 10.1016/j.phymed.2008.12.011. Epub 2009 Feb 6. Phytomedicine. 2009. PMID: 19201177
-
[Insulin resistance-reducing effect of a new thiazolidinedione derivative, pioglitazone].Nihon Yakurigaku Zasshi. 2001 May;117(5):335-42. doi: 10.1254/fpj.117.335. Nihon Yakurigaku Zasshi. 2001. PMID: 11411343 Review. Japanese.
-
Pioglitazone: beyond glucose control.Expert Rev Cardiovasc Ther. 2010 Aug;8(8):1057-67. doi: 10.1586/erc.10.98. Expert Rev Cardiovasc Ther. 2010. PMID: 20670183 Review.
Cited by
-
PPARγ Agonists Attenuate Palmitate-Induced ER Stress through Up-Regulation of SCD-1 in Macrophages.PLoS One. 2015 Jun 10;10(6):e0128546. doi: 10.1371/journal.pone.0128546. eCollection 2015. PLoS One. 2015. PMID: 26061913 Free PMC article.
-
Endoplasmic reticulum stress: implications for inflammatory bowel disease pathogenesis.Curr Opin Gastroenterol. 2010 Jul;26(4):318-26. doi: 10.1097/MOG.0b013e32833a9ff1. Curr Opin Gastroenterol. 2010. PMID: 20495455 Free PMC article. Review.
-
Endoplasmic reticulum stress in liver disease.J Hepatol. 2011 Apr;54(4):795-809. doi: 10.1016/j.jhep.2010.11.005. Epub 2010 Nov 13. J Hepatol. 2011. PMID: 21145844 Free PMC article. Review.
-
Pharmacological Modulators of Endoplasmic Reticulum Stress in Metabolic Diseases.Int J Mol Sci. 2016 Feb 1;17(2):192. doi: 10.3390/ijms17020192. Int J Mol Sci. 2016. PMID: 26840310 Free PMC article. Review.
-
Adiponectin suppresses endoplasmic reticulum stress in nonalcoholic steatohepatitis.Exp Ther Med. 2011 Nov;2(6):1035-1040. doi: 10.3892/etm.2011.348. Epub 2011 Sep 2. Exp Ther Med. 2011. PMID: 22977616 Free PMC article.
